Skip to main content
Equibles
IDXX logo

IDXX · Idexx Laboratories Inc /De

Track IDXX — free

Use IDXX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$538.99 -6.17 (-1.13%) At close · Sep 2
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$42.95B
Shares
78.78M

IDXX metrics

90 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$538.99
Market cap
$42.95B

Price action

19 metrics
Price change (1W)
-0.9%
Price change (30D)
-4.0%
Price change (3M)
-1.0%
Price change (6M)
-14.2%
Price change (YTD)
-19.4%
Price change (1Y)
-15.8%
Trailing year
Price change (5Y)
-19.5%
52-week high
$766.68
52-week low
$526.44
Change from 52-week high
-28.9%
Change from 52-week low
+3.6%
Annualized volatility
32.2%
Beta
0.9
RSI (14D)
43.9
Price vs SMA 50
-2.5%
Price vs SMA 200
-10.5%
Avg volume (3M)
624,216
Relative volume
0.7
Average dollar volume
$349.49M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
78.78M

Valuation

12 metrics
P / E (TTM)
38.3
Trailing earnings · reciprocal yield 2.6%
PEG ratio
2.2
EV / revenue
9.5×
reciprocal yield 10.5%
EV / EBITDA
26.8×
reciprocal yield 3.7%
EV / EBIT
29.6×
reciprocal yield 3.4%
P / sales
9.4×
reciprocal yield 10.6%
P / book
26.6
reciprocal yield 3.8%
FCF yield
2.9%
TTM · current market cap
Buyback yield
2.7%
P / FCF
34.2
reciprocal yield 2.9%
P / operating cash flow
31.3
reciprocal yield 3.2%
Earnings yield
2.7%

Historical valuation

8 metrics
P / E historical average (3Y)
46.7×
reciprocal yield 2.1%
P / E historical average (5Y)
50.8×
reciprocal yield 2.0%
EV / revenue historical average (3Y)
10.9×
reciprocal yield 9.2%
EV / revenue historical average (5Y)
11.5×
reciprocal yield 8.7%
EV / EBIT historical average (3Y)
35.9×
reciprocal yield 2.8%
EV / EBIT historical average (5Y)
39.2×
reciprocal yield 2.5%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
62.4%
Operating margin
32.0%
Trailing 12 months
Net margin
25.0%
Gross profit (TTM)
$2.84B
Operating profit (TTM)
$1.46B
Net income (TTM)
$1.14B
Trailing 12 months
Diluted EPS (TTM)
$14.23
FCF margin
27.5%
Effective tax rate
20.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+9.7%
Year over year
Net income growth YoY
+15.1%
Revenue (TTM)
$4.55B
Trailing 12 months
EPS growth YoY
+17.6%
Shares change YoY
-2.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+8.5%
Revenue CAGR (5Y)
+9.7%
EPS CAGR (3Y)
+17.7%
EPS CAGR (5Y)
+14.3%
FCF CAGR (3Y)
+38.9%
FCF CAGR (5Y)
+14.3%

Quality

14 metrics
Return on equity
70.7%
Return on assets
33.1%
Debt / equity
0.3
Current ratio
1.2
EBITDA (TTM)
$1.61B
Free cash flow (TTM)
$1.25B
Quick ratio
0.9
Interest coverage
38.6
Net debt / EBITDA
0.2
Return on invested capital
62.6%
Trailing 12 months
Net cash
−$252.93M
Latest balance sheet
Cash & equivalents
$196.93M
Total assets
$3.44B
Total debt
$449.86M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.37B
Capital expenditures (TTM)
$117.18M
R&D (TTM)
$261.46M
SG&A (TTM)
—
Stock compensation (TTM)
$62.97M
R&D / revenue
5.7%
Stock compensation / revenue
1.4%

Ownership (13F)

3 metrics
13F filers
1,288
13F filer change QoQ
-31
Institutional ownership
93.7%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 2.6 days to cover
Days to cover
2.6d
Short-squeeze score
55 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 874716 CUSIP 45168D104 13F (30d) 775 filings 757 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)